Back to dashboard
All PlansPrior AuthMedium impact

Pharmacy Medical Policy Updates

Blue Cross Blue Shield of Kansas·KS · Endocrinology, Oncology, Neurology +4 more·Pharmacy
Effective date
May 1, 2025
We identified it
Jun 19, 2026
Days to comply

Summary

Multiple pharmacy medical policies for specialized medications and conditions have been updated by BCBSKS, effective May 1, 2025. This includes policies for conditions like ATTR Amyloidosis, Dry Eye Disease, GLP-1 medications, Weight Management drugs, and various rare disease treatments that may require prior authorization changes.

Action Required

Action needed
By May 1, 2025: Clinical and billing teams must review updated pharmacy medical policies for affected medications including Amifapridine, GLP-1 drugs, Elagolix/Reugolix, weight management medications, and other listed drugs. Access specific medication policies at https://www.bcbsks.com/providers/precertification-prior-authorization to verify current prior authorization requirements. Update prior authorization workflows and medication lists in practice management systems accordingly.